Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uterine Tubes01:16

Uterine Tubes

2.3K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.

Practical radiation oncology·2026
Same author

Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries.

The Lancet. Global health·2026
Same author

Optimizing the delivery of care to patients with advanced epithelial ovarian cancer receiving first-line maintenance treatment with a poly(ADP-ribose) polymerase inhibitor.

Current medical research and opinion·2026
Same author

Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting.

HemaSphere·2026
Same author

Signaling Under Stress: Targeting the Glucocorticoid Receptor in Cancer.

Cancer research·2026
Same author

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.

Lancet (London, England)·2026

Related Experiment Video

Updated: Feb 4, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.3K

Uterine sarcomas.

Nomonde Mbatani1,2, Alexander B Olawaiye3, Jaime Prat4

  • 1Department of Obstetrics and Gynecology, Groote Schuur Hospital/University of Cape Town, Cape Town, South Africa.

International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|October 12, 2018
PubMed
Summary

Uterine sarcomas, rare cancers, include subtypes like leiomyosarcomas and endometrial stromal sarcomas. Tumor stage is the most critical factor influencing prognosis for these uterine cancers.

Keywords:
AdenosarcomasCarcinosarcomasEndometrial stromal sarcomasFIGO Cancer ReportLeiomyosarcomasUndifferentiated endometrial sarcomasUterine sarcomas

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K
Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
08:07

Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions

Published on: May 26, 2023

1.9K

Related Experiment Videos

Last Updated: Feb 4, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K
Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
08:07

Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions

Published on: May 26, 2023

1.9K

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Cancer Research

Background:

  • Uterine sarcomas represent 3%-7% of all uterine cancers.
  • Leiomyosarcomas are the most common subtype, often high-grade with poor prognosis.
  • Other subtypes include endometrial stromal sarcomas, adenosarcomas, and carcinosarcomas, each with distinct behaviors.

Purpose of the Study:

  • To review the classification and prognostic factors of uterine sarcomas.
  • To differentiate the clinical behavior and outcomes of various uterine sarcoma subtypes.
  • To emphasize the importance of tumor stage in predicting patient outcomes.

Main Methods:

  • Review of current literature and classification systems for uterine sarcomas.
  • Analysis of prognostic indicators based on histologic subtype and tumor characteristics.
  • Comparison of survival outcomes across different uterine sarcoma categories.

Main Results:

  • Leiomyosarcomas are predominantly high-grade with poor prognosis, even at early stages.
  • Low-grade endometrial stromal sarcomas exhibit indolent behavior and long-term survival.
  • Adenosarcomas generally have a favorable prognosis, with exceptions for specific invasive features. Carcinosarcomas often have a worse prognosis than high-grade endometrial carcinomas.

Conclusions:

  • Accurate histologic classification is crucial for understanding uterine sarcoma behavior.
  • Tumor stage is the paramount prognostic factor across all uterine sarcoma subtypes.
  • Distinguishing between high-grade and low-grade sarcomas is essential for predicting patient outcomes.